Sexual Function is the 5th Vital Sign1
                                              [Sexual Dysfunction]               
Is a Symptom of an Underlying Medical Condition(s)1
We Identify and Correct the Underlying Condition(s)2,3
To Optimize Your Health, Sexual Performance, &
Quality Life

Cavender Health is a Executive METABOLIC SYNDROME INTERVENTION PROGRAM that is Available to All Individuals Who Seek a Comprehensive and Personal Approach to their Healthcare.


Primary Focus: Cardiovascular and Metabolic Disease Risk Reduction through Diagnoses and Management of Metabolic and Endocrine Conditions, Including Sex Hormones Disorders and Sexual Health with Improvement of Quality of Life.


Disease Specific Lifestyle Modification Serves as the Foundation of All Treatment Programs and Includes Aggressive Body Composition and Weight Loss Management Interventions, Utilizing the FDA Approved Weight Loss Medications for those who Qualify Under the State Regulations.


I. METABOLIC CONDITIONS (METABOLIC SYNDROME):                                         Central Weight


1. Sleep Disorders

2. Insulin Resistance, Pre-Diabetes, & Type II Diabetes                                             Visceral Adipose

3. Central Weight, Overweight, & Obesity  (VAT)                                                                   Tissue

4. Cholesterol Disorders                                                                                                                  (VAT)

5. High Blood Pressure 

                                                                                                                                                                                                               Target Tissue

II. ENDOCRINE DISORDERS (BARRIERS                                                                   For 

     to Achieving Health and Quality of Life Goals:                                                              Metabolic Disease                                                                                                                                                                                                                                       &                                      

1. Hypothyroidism                                                                                                                     Sexual Medicine

2. Adrenal Dysfunction                                                                                                               Intervention

3. Male Sex Hormone Disorders or Deficiencies:

       Low Testosterone (Low T)

       High Estrogen

       Low Libido (Low Sexual Desire)

       Erectile Dysfunction (ED)

4. Female Sex Hormone Disorders or Deficiencies:

       Polycystic Ovarian Syndrome (PCOS)

       Premenstrual Syndrome (PMS) and Menstrual Cycle Dysfunction

       Hormonal Changes: Peri-Menopause, Menopause Transition, Menopause Syndrome

       Female Sexual Dysfunction, and Hypoactive Sexual Desire



Richard K. Cavender, MD, FACEP
Medical Director 
Cavender & CardioMetabolic Health
Center for  CardioMetabolic, Sports, & Sexual Medicine
Auguste Rodin


“Cavender Health maximizes specialty evaluation and intervention via  its Clinical Care and Clinical Research Collaborations with Endocrinology Associates/Elena A. Christofides, MD, FACE. Dr. Christofides is a Nationally Recognized Clinical and Research Endocrinologist and Dr. Cavender has accepted the role as Clinical Sub-Investigator under the Endocrinology Direction of Dr. Christofides.”

Cavender Health maximizes clinical care and intervention through a collaborative relationship with cardiologist,  C.G. Reddy, M.D., FACC, FSCAI, ABVM.

Dr. Reddy specializes in preventive cardiology, as well as, coronary and peripheral vascular interventions including cardiac catheterizations, peripheral vascular angiograms, and permanent pacemaker implants. 

164 Wetherby Lane
Westerville, Ohio 43081

1. Shabsigh, R., et al. The Triad of Erectile Dysfunction, Hypogonadism and the Metabolic Syndrome. Int. J. Clin. Pract. 2008: doi: 10.1111/j.1742-1241.2008.01696.x

2. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M. Elahi D, Hayes FJ.  Increasing Insulin Resistance Is Associated with a Decrease in Leydig Cell Testosterone Secretion in MenJ Clin Endocrinol Met 90(5):2636-2641, 2005.

3. Kapoor D, Goodwin E, Channer KS, Jones TH.  Testosterone Replacement Therapy Improves Insulin Resistance, Glycaemic Control, Visceral Adiposity and Hypercholesterolaemia in Hypogonadal Men with Type 2 DiabetesEuro J  Endocrinol. 154, 899-906, 2006.